Chengdu Kanghua Biological Products Co., Ltd. (SHE:300841)

China flag China · Delayed Price · Currency is CNY
71.42
+0.40 (0.56%)
Feb 13, 2026, 3:04 PM CST
Market Cap9.28B +44.6%
Revenue (ttm)1.21B -26.5%
Net Income181.86M -66.7%
EPS1.40 -66.0%
Shares Out129.95M
PE Ratio51.03
Forward PEn/a
Dividend1.00 (1.41%)
Ex-Dividend DateMay 20, 2025
Volume1,455,445
Average Volume2,238,503
Open71.29
Previous Close71.02
Day's Range70.54 - 72.26
52-Week Range50.02 - 94.30
Beta0.63
RSI45.44
Earnings DateApr 28, 2026

About SHE:300841

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 620
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 300841
Full Company Profile

Financial Performance

In 2024, SHE:300841's revenue was 1.43 billion, a decrease of -9.23% compared to the previous year's 1.58 billion. Earnings were 398.65 million, a decrease of -21.71%.

Financial Statements